Buy
Sell
Share Name Share Symbol Market Type
Merck and Co Inc NYSE:MRK NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  -0.51 -0.65% 77.66 3,450 12:02:01

Merck Says Organon To Acquire Alydia Health

30/03/2021 1:20pm

Dow Jones News


Merck (NYSE:MRK)
Historical Stock Chart


From Mar 2021 to May 2021

Click Here for more Merck Charts.

By Michael Dabaie

 

Merck & Co. Inc. said that after the intended Merck spinoff of Organon, Organon will acquire Alydia Health.

Alydia Health is a commercial-stage medical device company focused on preventing maternal morbidity and mortality caused by postpartum hemorrhage or abnormal postpartum uterine bleeding.

Organon will be a global healthcare company formed through a spinoff from Merck to focus on women's health.

Organon agreed to acquire Alydia Health for up to $240 million total consideration, including $215 million upfront plus a $25 million contingent milestone payment.

Of the upfront payment, $50 million will be paid prior to the spinoff of Organon, $165 million will be paid by Organon upon the close of the acquisition, and the remainder will be paid by Organon upon achievement of the milestone.

Closing will be subject to completion of the spinoff of Organon from Merck, currently anticipated late in the second quarter of 2021.

 

Write to Michael Dabaie at michael.dabaie@wsj.com

 

(END) Dow Jones Newswires

March 30, 2021 08:05 ET (12:05 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

1 Year Merck Chart

1 Year Merck Chart

1 Month Merck Chart

1 Month Merck Chart
ADVFN Advertorial
Your Recent History
NYSE
MRK
Merck
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210511 11:17:56